Company Filing History:
5 out of 845 
2 out of 3,539 
Years Active: 2013-2016
Title: Therese Buskas: Innovator in Glycopeptide Research
Introduction
Therese Buskas is a prominent inventor based in Athens, GA (US), known for her significant contributions to the field of glycopeptide research. With a total of five patents to her name, she has made remarkable strides in developing therapeutic and prophylactic vaccines.
Latest Patents
One of her latest patents is titled "Glycopeptide and uses thereof." This invention involves a glycolipopeptide that comprises a carbohydrate component, a peptide component, and a lipid component, intended for use as a therapeutic or prophylactic vaccine. Additionally, she has developed monoclonal and polyclonal antibodies that recognize the glycolipopeptide, along with various applications for these antibodies. Another notable patent is "Anthrax carbohydrates, synthesis and uses thereof," which presents the isolation, characterization, and synthesis of oligosaccharides. This patent also includes antibodies that bind to these saccharide moieties and outlines various methods for their use.
Career Highlights
Therese has worked with esteemed organizations such as the University of Georgia Research Foundation, Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. Her work in these institutions has significantly advanced the understanding and application of glycopeptides in medical research.
Collaborations
Throughout her career, Therese has collaborated with notable colleagues, including Geert-Jan Boons and Sampat Ingale, contributing to the advancement of her research and innovations.
Conclusion
Therese Buskas is a trailblazer in glycopeptide research, with a strong portfolio of patents that reflect her innovative spirit and dedication to advancing medical science. Her work continues to impact the field significantly.